119 related articles for article (PubMed ID: 10070983)
1. From the Food and Drug Administration.
Nightingale SL
JAMA; 1999 Mar; 281(9):786. PubMed ID: 10070983
[No Abstract] [Full Text] [Related]
2. Arthritis medicines and cardiovascular events--"house of coxibs".
Topol EJ
JAMA; 2005 Jan; 293(3):366-8. PubMed ID: 15623849
[No Abstract] [Full Text] [Related]
3. Celecoxib approved as NSAID with some concessions on class warning.
Miller JL
Am J Health Syst Pharm; 1999 Mar; 56(5):403. PubMed ID: 10096694
[No Abstract] [Full Text] [Related]
4. Arthritis drug approved for polyp prevention blazes trail for other prevention trials.
Smigel K
J Natl Cancer Inst; 2000 Feb; 92(4):297-9. PubMed ID: 10675374
[No Abstract] [Full Text] [Related]
5. Raising the safety bar--the FDA's coxib meeting.
Okie S
N Engl J Med; 2005 Mar; 352(13):1283-5. PubMed ID: 15800221
[No Abstract] [Full Text] [Related]
6. From the Food and Drug Administration.
Henney JE
JAMA; 2000 Mar; 283(9):1131. PubMed ID: 10703765
[No Abstract] [Full Text] [Related]
7. Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
Couzin J
Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414
[No Abstract] [Full Text] [Related]
8. Outfoxing pathways of pain. 'COX-2' drugs are easier on stomach.
Brink S
US News World Rep; 1998 Dec; 125(23):62. PubMed ID: 10345496
[No Abstract] [Full Text] [Related]
9. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
Gibofsky A
J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
[TBL] [Abstract][Full Text] [Related]
10. [Celecoxib].
Fux R; Mörike K; Gleiter CH
Dtsch Med Wochenschr; 2002 Apr; 127(15):803-4. PubMed ID: 11951138
[No Abstract] [Full Text] [Related]
11. Decisions loom on selective COX-2 inhibitors.
Miller JL
Am J Health Syst Pharm; 1999 Jan; 56(2):106-7. PubMed ID: 10030522
[No Abstract] [Full Text] [Related]
12. Celecoxib: a COX-2 inhibitor.
Andrews SA; Wallace CK; Davis RL
Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
[No Abstract] [Full Text] [Related]
13. [Clinical use of COX-2 inhibitors].
Ristić GG; Stefanović DZ
Vojnosanit Pregl; 2001; 58(3):283-95. PubMed ID: 11548555
[No Abstract] [Full Text] [Related]
14. The coxibs, selective inhibitors of cyclooxygenase-2.
FitzGerald GA; Patrono C
N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
[No Abstract] [Full Text] [Related]
15. Labeling changes for arthritis drug.
FDA Consum; 2002; 36(5):6. PubMed ID: 12412538
[No Abstract] [Full Text] [Related]
16. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
Chan FK; Hung LC; Suen BY; Wu JC; Lee KC; Leung VK; Hui AJ; To KF; Leung WK; Wong VW; Chung SC; Sung JJ
N Engl J Med; 2002 Dec; 347(26):2104-10. PubMed ID: 12501222
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib for arthritis.
Med Lett Drugs Ther; 1999 Jan; 41(1045):11-2. PubMed ID: 9949762
[No Abstract] [Full Text] [Related]
18. Tailoring arthritis therapy in the wake of the NSAID crisis.
Olsen NJ
N Engl J Med; 2005 Jun; 352(25):2578-80. PubMed ID: 15972863
[No Abstract] [Full Text] [Related]
19. Coxibs and cardiovascular risk.
Allen MJ; McLean-Veysey P; Fleming I
CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098
[No Abstract] [Full Text] [Related]
20. Rofecoxib vs celecoxib vs acetaminophen for treatment of osteoarthritis.
Henderson P
JAMA; 2002 Apr; 287(14):1799; author reply 1799-800. PubMed ID: 11939848
[No Abstract] [Full Text] [Related]
[Next] [New Search]
